Aerovate Therapeutics (AVTE) Earnings Date & Reports

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AVTE is expected to report earnings to rise 117.52% to -41 cents per share on May 19

Aerovate Therapeutics AVTE Stock Earnings Reports

Q1'25

Est.

$-0.41

Q4'24

Beat

by $0.21

Q3'24

Beat

by $0.02

Q2'24

Missed

by $0.01

Q1'24

Missed

by $0.07

The last earnings report on March 26 showed earnings per share of -18 cents, beating the estimate of -40 cents. With 22.38K shares outstanding, the current market capitalization sits at 73.04M.

View a ticker or compare two or three

Compare

AVTE